Impacts of Different Training Modes (Intense Versus Ordinary) on the I

Intensity-dependent Impacts of Training on Growth Factors BDNF and Cognitive Functions in Persons With Multiple Sclerosis - a Single-center Randomized Controlled Trial

CompletedNot a drug-phase studyMS (type not specified)NCT02571335

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Intensive Training

Compared with

  • Normal Training

What it measured

Main measures

  • Neurotrophic Factor BDNF

    3-weeks

    MRI lesions

Other measures (6)

  • Maximum Oxygen consumption (VO2peak)

    3-weeks

    Physical function

  • Maximum heart rate (HRmax)

    3-weeks

  • Maximum workload (Loadmax)

    3-weeks

  • Fatigue

    3-weeks

    Thinking and memoryFatigue

  • Health-related Quality of life

    3-weeks

    Mood and sleepQuality of life (reported by participants)

  • Cognitive Functions

    3-weeks

    MRI lesionsThinking and memory

Who could take part

MS (type not specified) · 18 to 75 · EDSS 1.0 to 6.0

Show the full criteria

Inclusion criteria

Key inclusion criteria for the participants' eligibility are a definite MS diagnosis (McDonald criteria). Participants fulfilling the key inclusion and the following criteria are eligible for this study * EDSS 1.0 - 6.0 * Age 19 - 75 years The presence of any one of the following exclusion criteria will lead to exclusion of the participant: * Persistent infections * Severe cardiovascular and pulmonal diseases (renal failure, hepatic dysfunction, cardiovascular disease) * Severe cardiovascular exacerbations (RR > 240/120, HR above the age predicted maximum of 220-Age) during training * Immunosuppressive therapy the day of CPET * Life style factors and / or persistent addictions (drug or alcohol abuse) * Inability to follow the study procedures (due to psychological disorders or dementia) * Insufficient knowledge of the project language (German) * Women who are pregnant or breast feeding, * Intention to become pregnant during the course of the study, * Lack of safe contraception, defined as: Female participants of childbearing potential, not using and not willing to continue using a medically reliable method of contraception for the entire study duration, such as oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices, or who are not using any other method considered sufficiently reliable by the investigator in individual cases. * Participation in another study with investigational drug within the 30 days preceding and during the present study, * Previous enrolment into the current study, * Enrolment of the investigator, his / her family members, employees and other dependent persons, * Specific exclusions for the disease under study, * Specific concomitant therapy washout requirements prior to and/or during study participation, * Dietary restrictions Exclusion Criteria: Criteria in which the participant withdraws from this study may be the following: * Inability to comply with the daily schedule * Strong symptom exacerbations * Withdrawal of informed consent * Non-compliance * Disease progression or relapse

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system, accompanied by varying inflammatory manifestations, demyelinization and axonal loss. With chronic progressive or relapsing-remitting disease onsets persons with MS (pwMS) progressively develop impaired functional capacity and show reduced physical activity and cognitive decline compared to healthy controls. The primary aims of rehabilitation in pwMS are therefore to increase levels of activity and participation leading to increase independence of the participants. In general exercise ranges from passive physiotherapy-based interventions to submaximal endurance training sessions. Current recommendations advise pwMS that exercise should be matched with the individual performance capacities. Exercise training in pwMS then has the potential to target and improve many components outlined in the ICF-model. Cytokines and neurotrophic factors have received increased attention in MS research and addressed the brain-derived neurotrophic factor (BDNF) as an important mediator of neuronal regeneration linking the effects of exercise with MS pathogenesis. Data show positive connections between elevated neurotrophin concentrations, induction of neuroplasticity, recovery of the motor and cognitive functions and the applied training intensities. Similarly, intensive and progressive exercise bouts seem to have greater benefits on cardiorespiratory fitness and maximum voluntary strength in elderly and seniors with dementia. Therefore, specific exercise prescriptions may be necessary for targeting the specific impairments also in pwMS. This study aims to evaluate two different training modalities (intensive versus normal) in pwMS. It is expected that both modalities will improve cardiorespiratory fitness and cognitive functions in pwMS. Based on the findings that higher training intensities facilitate greater benefits, it is expected that pwMS will tolerate the intensive training intensities and show positive connections to elevated neurotrophin concentrations. The results will to help to clearer understand the benefits of each type of exercise conveyed for pwMS and will assist in the development of patient-specific exercise prescriptions.

Papers

Loading reviews and guidelines…

History

    1. Started

      Sept 2015

    2. Main results due

      Aug 2016

    3. Finished

      Aug 2016

    Assembled by software from public sources.